Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetics, Population | 4 | 2023 | 188 | 3.090 |
Why?
|
| Exome | 1 | 2023 | 1034 | 0.590 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2023 | 2640 | 0.570 |
Why?
|
| Genetic Variation | 1 | 2022 | 1502 | 0.500 |
Why?
|
| Genomics | 1 | 2023 | 1499 | 0.480 |
Why?
|
| Multiple Sclerosis | 2 | 2025 | 329 | 0.320 |
Why?
|
| Genotype | 2 | 2023 | 2568 | 0.270 |
Why?
|
| Cellular Senescence | 1 | 2024 | 161 | 0.210 |
Why?
|
| Androgens | 1 | 2025 | 279 | 0.200 |
Why?
|
| Africa, Southern | 1 | 2022 | 7 | 0.200 |
Why?
|
| Genetic Structures | 1 | 2022 | 3 | 0.200 |
Why?
|
| Frailty | 1 | 2024 | 104 | 0.200 |
Why?
|
| Heterozygote | 1 | 2023 | 672 | 0.180 |
Why?
|
| Cortical Bone | 1 | 2018 | 3 | 0.160 |
Why?
|
| Cancellous Bone | 1 | 2018 | 7 | 0.160 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 647 | 0.160 |
Why?
|
| Osteoporotic Fractures | 1 | 2018 | 24 | 0.150 |
Why?
|
| Immunologic Factors | 1 | 2019 | 174 | 0.150 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2018 | 54 | 0.150 |
Why?
|
| Software | 1 | 2023 | 684 | 0.150 |
Why?
|
| Disease Progression | 2 | 2025 | 2077 | 0.150 |
Why?
|
| Fractures, Bone | 2 | 2018 | 188 | 0.140 |
Why?
|
| Bone Density | 2 | 2018 | 319 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 265 | 0.140 |
Why?
|
| Genome, Human | 1 | 2023 | 1273 | 0.130 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2016 | 59 | 0.130 |
Why?
|
| Biomarkers | 1 | 2024 | 3096 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1122 | 0.120 |
Why?
|
| Phenotype | 1 | 2023 | 4263 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 302 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 369 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2917 | 0.090 |
Why?
|
| DNA Methylation | 2 | 2015 | 1007 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 2 | 2024 | 880 | 0.080 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2011 | 138 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1699 | 0.080 |
Why?
|
| Humans | 11 | 2025 | 125392 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1711 | 0.070 |
Why?
|
| Middle Aged | 7 | 2025 | 26990 | 0.070 |
Why?
|
| Spinal Injuries | 1 | 2006 | 28 | 0.060 |
Why?
|
| Spinal Fractures | 1 | 2006 | 38 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 2 | 2024 | 507 | 0.060 |
Why?
|
| Aged | 5 | 2025 | 19896 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2006 | 314 | 0.060 |
Why?
|
| Kidney Function Tests | 1 | 2024 | 129 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 5185 | 0.050 |
Why?
|
| Kidney | 1 | 2010 | 1369 | 0.050 |
Why?
|
| Risk Factors | 4 | 2024 | 10331 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2024 | 6168 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2025 | 4824 | 0.040 |
Why?
|
| Interferon-beta | 1 | 2019 | 52 | 0.040 |
Why?
|
| Adult | 5 | 2024 | 29692 | 0.040 |
Why?
|
| Male | 6 | 2025 | 61663 | 0.040 |
Why?
|
| Femur Neck | 1 | 2018 | 9 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 275 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6607 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2018 | 178 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2018 | 117 | 0.040 |
Why?
|
| Female | 6 | 2024 | 66885 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 1689 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1420 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 4648 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1361 | 0.030 |
Why?
|
| Age Factors | 2 | 2015 | 2827 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 205 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 9069 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 553 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 1615 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2011 | 24 | 0.020 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2011 | 10 | 0.020 |
Why?
|
| G2 Phase | 1 | 2011 | 44 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2011 | 49 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3154 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2107 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2820 | 0.020 |
Why?
|
| Cystatin C | 1 | 2010 | 58 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2011 | 135 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6345 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3468 | 0.020 |
Why?
|
| Europe | 1 | 2010 | 356 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 391 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2010 | 604 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 19373 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1080 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 760 | 0.020 |
Why?
|
| Lifting | 1 | 2006 | 1 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2006 | 12 | 0.020 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2006 | 21 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2006 | 40 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2006 | 42 | 0.020 |
Why?
|
| Dementia | 1 | 2011 | 452 | 0.020 |
Why?
|
| Spine | 1 | 2006 | 142 | 0.020 |
Why?
|
| Radiography | 1 | 2006 | 823 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 1140 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 5849 | 0.010 |
Why?
|